12-109556171-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_052845.4(MMAB):​c.*857G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.526 in 453,090 control chromosomes in the GnomAD database, including 65,031 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 25473 hom., cov: 31)
Exomes 𝑓: 0.51 ( 39558 hom. )

Consequence

MMAB
NM_052845.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.277

Publications

25 publications found
Variant links:
Genes affected
MMAB (HGNC:19331): (metabolism of cobalamin associated B) This gene encodes a protein that catalyzes the final step in the conversion of vitamin B(12) into adenosylcobalamin (AdoCbl), a vitamin B12-containing coenzyme for methylmalonyl-CoA mutase. Mutations in the gene are the cause of vitamin B12-dependent methylmalonic aciduria linked to the cblB complementation group. Alternatively spliced transcript variants have been found. [provided by RefSeq, Apr 2011]
MMAB Gene-Disease associations (from GenCC):
  • methylmalonic aciduria, cblB type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-109556171-C-G is Benign according to our data. Variant chr12-109556171-C-G is described in ClinVar as Benign. ClinVar VariationId is 307047.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.718 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMABNM_052845.4 linkc.*857G>C 3_prime_UTR_variant Exon 9 of 9 ENST00000545712.7 NP_443077.1 Q96EY8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMABENST00000545712.7 linkc.*857G>C 3_prime_UTR_variant Exon 9 of 9 1 NM_052845.4 ENSP00000445920.1 Q96EY8

Frequencies

GnomAD3 genomes
AF:
0.567
AC:
86129
AN:
151894
Hom.:
25429
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.724
Gnomad AMI
AF:
0.587
Gnomad AMR
AF:
0.502
Gnomad ASJ
AF:
0.532
Gnomad EAS
AF:
0.298
Gnomad SAS
AF:
0.390
Gnomad FIN
AF:
0.464
Gnomad MID
AF:
0.563
Gnomad NFE
AF:
0.536
Gnomad OTH
AF:
0.581
GnomAD2 exomes
AF:
0.491
AC:
64019
AN:
130412
AF XY:
0.487
show subpopulations
Gnomad AFR exome
AF:
0.737
Gnomad AMR exome
AF:
0.462
Gnomad ASJ exome
AF:
0.552
Gnomad EAS exome
AF:
0.298
Gnomad FIN exome
AF:
0.464
Gnomad NFE exome
AF:
0.539
Gnomad OTH exome
AF:
0.506
GnomAD4 exome
AF:
0.505
AC:
152056
AN:
301078
Hom.:
39558
Cov.:
0
AF XY:
0.498
AC XY:
85415
AN XY:
171490
show subpopulations
African (AFR)
AF:
0.729
AC:
6237
AN:
8552
American (AMR)
AF:
0.466
AC:
12690
AN:
27256
Ashkenazi Jewish (ASJ)
AF:
0.554
AC:
5966
AN:
10774
East Asian (EAS)
AF:
0.302
AC:
2772
AN:
9192
South Asian (SAS)
AF:
0.423
AC:
25245
AN:
59626
European-Finnish (FIN)
AF:
0.470
AC:
5804
AN:
12358
Middle Eastern (MID)
AF:
0.603
AC:
692
AN:
1148
European-Non Finnish (NFE)
AF:
0.540
AC:
85406
AN:
158150
Other (OTH)
AF:
0.517
AC:
7244
AN:
14022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
4920
9840
14759
19679
24599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.567
AC:
86235
AN:
152012
Hom.:
25473
Cov.:
31
AF XY:
0.557
AC XY:
41408
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.724
AC:
30030
AN:
41456
American (AMR)
AF:
0.503
AC:
7673
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.532
AC:
1848
AN:
3472
East Asian (EAS)
AF:
0.298
AC:
1542
AN:
5170
South Asian (SAS)
AF:
0.390
AC:
1878
AN:
4820
European-Finnish (FIN)
AF:
0.464
AC:
4892
AN:
10542
Middle Eastern (MID)
AF:
0.554
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
0.536
AC:
36449
AN:
67974
Other (OTH)
AF:
0.582
AC:
1225
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1885
3770
5655
7540
9425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.493
Hom.:
2539
Bravo
AF:
0.581
Asia WGS
AF:
0.384
AC:
1336
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Methylmalonic aciduria, cblB type Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.86
DANN
Benign
0.73
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs877710; hg19: chr12-109993976; COSMIC: COSV57171067; COSMIC: COSV57171067; API